Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Facilitation of primary PCI with ReoPro.
van 't Hof AW, Rasoul S, Ottervanger JP, Dambrink JH. van 't Hof AW, et al. Among authors: rasoul s. Eur Heart J. 2005 Aug;26(15):1563-4; author reply 1564-5. doi: 10.1093/eurheartj/ehi346. Epub 2005 Jun 7. Eur Heart J. 2005. PMID: 15941724 No abstract available.
Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction.
van 't Hof AW, Rasoul S, van de Wetering H, Ernst N, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink M, Zijlstra F, Ottervanger JP, de Boer MJ; On-TIME study group. van 't Hof AW, et al. Among authors: rasoul s. Am Heart J. 2006 Jun;151(6):1255.e1-5. doi: 10.1016/j.ahj.2006.03.014. Am Heart J. 2006. PMID: 16781231
Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison.
Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Suryapranata H, Hoorntje JC, Gosselink AT, van 't Hof AW; ELISA study group. Rasoul S, et al. J Thromb Thrombolysis. 2007 Dec;24(3):241-6. doi: 10.1007/s11239-007-0015-y. Epub 2007 Mar 2. J Thromb Thrombolysis. 2007. PMID: 17334935 Clinical Trial.
Are patients with non-ST elevation myocardial infarction undertreated?
Rasoul S, Ottervanger JP, Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT, Zijlstra F, Suryapranata H, van 't Hof AW. Rasoul S, et al. BMC Cardiovasc Disord. 2007 Mar 5;7:8. doi: 10.1186/1471-2261-7-8. BMC Cardiovasc Disord. 2007. PMID: 17338808 Free PMC article.
92 results